| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5509839 | Clinica Chimica Acta | 2017 | 6 Pages |
Abstract
The presence of neutropenia is significantly associated with low SVC, even after adjusting for other variables. Therefore, neutropenic patients had a higher risk of sub-therapeutic SVC compared with non-neutropenic patients. We recommended that vancomycin therapy should be monitored with TDM-guided optimization of dosage and intervals, especially in neutropenic patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Min Hyuk Choi, Yeon Hwa Choe, Sang-Guk Lee, Seok Hoon Jeong, Jeong-Ho Kim,